|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net loss | |||||
| Net income (loss) | |||||
| Adjustments to reconcile Net income (loss) to net cash provided by (used in) operating activities: | |||||
| Unrealized loss (gain) on derivative instruments | |||||
| Depreciation, depletion and amortization | |||||
| Share-based compensation | |||||
| Loss on early extinguishment of debt | |||||
| Change in deferred tax provision | |||||
| Asset impairment | |||||
| Gain on sale of assets | |||||
| Bargain purchase gain | |||||
| Force majeure settlement | |||||
| Other postretirement benefits gain, net | |||||
| Lower of cost or NRV inventory adjustment | |||||
| Net periodic benefit cost | |||||
| Other non-cash items - net | |||||
| Change in operating assets and liabilities, net of acquisition: | |||||
| Accounts receivable - net | |||||
| Non-trade receivables | |||||
| Manufacturing credit receivable | |||||
| Due from affiliates | |||||
| Inventories | |||||
| Prepaid and other current assets | |||||
| Accounts payable, trade | |||||
| Due to affiliates | |||||
| Accrued and other current liabilities | |||||
| Ravenswood retiree medical settlement | |||||
| PBGC settlement | |||||
| Other - net | |||||
| Net cash provided by (used in) operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Capital expenditures | |||||
| Proceeds from co-tenancy assets at Jamalco JV | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Acquisition of subsidiary net of cash acquired | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Repayment of Senior Notes due 2025 | |||||
| Repayment of Senior Notes due 2028 | |||||
| Early redemption premiums paid | |||||
| Proceeds from issuance of Senior Notes due 2032 | |||||
| Proceeds from issuance of Convertible Senior Notes | |||||
| Repayments under Hawesville Term Loan | |||||
| Payment of deferred financing fees | |||||
| Purchase of capped calls related to Convertible Senior Notes | |||||
| Borrowings under revolving credit facilities | |||||
| U.S. and Iceland Revolving Credit Facilities | |||||
| Iceland Term Facility | |||||
| Repayments under revolving credit facilities | |||||
| U.S. and Iceland Revolving Credit Facilities | |||||
| Iceland Term Facility | |||||
| Casthouse Facility | |||||
| Vlissingen Facility Agreement | |||||
| Borrowings under facility agreements | |||||
| Casthouse Facility | |||||
| Vlissingen Facility Agreement | |||||
| Repayments under Grundartangi casthouse debt facility | |||||
| Contributions from joint venture partner | |||||
| Payments related to tax withholding for share-based compensation | |||||
| Carbon credit proceeds | |||||
| Carbon credit repayments | |||||
| Net cash provided by (used in) financing activities | |||||
| CHANGE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
| Supplemental Cash Flow Information: | |||||
| Cash paid for: | |||||
| Interest | |||||
| Income taxes, net of refunds | |||||
| Non-cash investing activities: | |||||
| Capital expenditures | |||||
| Capitalized interest | |||||
| Distribution of fixed assets to NCI | |||||
Loading...